Curis to Present at the 9th Annual BIO Investor Forum

Published October 4, 2010

Curis to Present at the 9th Annual BIO Investor Forum
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the company will be presenting at the 9th Annual BIO Investor Forum at 10:00 a.m. Pacific time (1:00 p.m. EDT) on October 6, 2010, in San Francisco. Dan Passeri, Curis’ President and Chief …
Read more on Business Wire

Mental health providers struggling
Advocates say mental illness costs billions a year in substance abuse, medical costs and lost productivity. And those needs have expanded in a bad economy. Yet, “mental health care is really the ugly stepchild of health care.”
Read more on The Cincinnati Enquirer

Bone drug may block breast tumours
The same mechanism that makes Amgen’s new bone drug denosumab an effective treatment for osteoporosis may also mean it could help prevent breast cancer, scientists said on Wednesday.
Read more on C-Health